Eden Research on BBC Radio 4's You & Yours

RNS Number : 7885E

Eden Research plc

11 May 2017

The following announcement has been released via RNS Reach, an investor communication service aimed at assisting listed and unlisted companies to distribute non-regulatory news releases such as marketing messages, corporate and product information into the public domain

Eden Research Plc

("Eden" or "Company")

Eden Research features on BBC Radio 4's You & Yours

Eden Research plc (AIM: EDEN), the AIM-listed company that provides breakthrough natural bio-control products and microencapsulation technologies to the global agrochemicals, animal health and consumer products industries, announces that yesterday's You & Yours, BBC Radio 4's consumer affairs programme, featured Eden Research plc's Mevalone, which used for the prevention and treatment of botrytis in table and wine grapes in a section of the programme labelled: The British innovation that's rejuvenating the French wine industry.

Shareholders can listen to the section from 23.45 until 30.14 here: http://www.bbc.co.uk/programmes/b08p5l79#play

Eden received approval for sale of Mevalone in France in January this year following extensive consideration by the French Authorities and Regulatory Agencies.

Eden Research plc	www.edenresearch.com
Sean Smith, Chief Executive Officer	Tel: 01285 359 555
Alex Abrey, Chief Financial Officer

Shore Capital and Corporate Limited	www.shorecap.com
Stephane Auton/Patrick Castle	Tel: 020 7408 4090

Walbrook PR Ltd	Tel: 020 7933 8780 or eden@walbrookpr.com
Paul McManus	Mob: 07980 541 893
Lianne Cawthorne	Mob: 07584 391 303

Notes:

Eden Research is a technology development and commercialisation company with intellectual property and expertise in encapsulation, terpenes and environmentally friendly technologies to provide naturally occurring solutions for the global agrochemicals, animal health, and consumer product industries.

Eden's encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. The technology uses yeast cells that are a by-product of numerous commercial production processes to deliver a slow release of natural compounds for agricultural and non-agricultural uses. Terpenes are already widely used in the food flavouring, cosmetics and pharmaceutical industries.

Historically, terpenes have had limited commercial use in the agrochemical sector due to their volatility, phytotoxicity and poor solubility. Eden's platform encapsulation technology provides a unique, environmentally friendly solution to these problems and enables terpenes to be used as effective, low-risk agrochemicals.

With leading consultants in their respective fields, the Company is developing these technologies through innovative research and a series of commercial production, marketing and distribution partnerships.

The Company has a number of patents and a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. To date, the Company has invested in the region of £12m in developing and protecting its intellectual property and seeking regulatory approval for products that rely upon the Company's technologies. Revenues earned by the Company have been modest whilst the Company has concentrated on securing patent protection for its intellectual property, gaining regulatory approvals, identifying suitable industrial partners, and entering into commercial agreements.

In May 2013, the three actives that comprise Eden's first commercial product, 3AEY, were approved as new ingredients for use in plant protection products. This represents a major milestone in the commercialisation of Eden's technology and is a significant accomplishment for any company. To illustrate this point, one should note that in all of 2013, Eden's approvals represented 3 of only 10 new active ingredients approved by the EC.